Reanalysis of Study in Hodgkin Lymphoma | 23% Reduction in Risk of Modified PFS

Liviu Niculescu, MD PhD, explains Reanalysis of Study in Hodgkin Lymphoma 23% Reduction in Risk of Modified PFS at Annual Meeting 2018